Ibiden (4062) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
13 Jun, 2025Executive summary
Net sales for Q1 FY2024 were ¥88,220 million, down 6.7% year-over-year, but operating profit rose 38.1% to ¥11,295 million.
Profit attributable to owners of parent increased 21.0% to ¥8,816 million compared to the same quarter last year.
Comprehensive income fell 42.9% year-over-year to ¥15,463 million, mainly due to lower valuation gains on securities.
Financial highlights
Gross profit improved to ¥25,614 million from ¥21,446 million year-over-year, despite lower sales.
Operating profit margin increased, with operating profit at ¥11,295 million versus ¥8,181 million last year.
Net cash provided by operating activities was ¥8,410 million, up from ¥5,208 million year-over-year.
Net cash used in investing activities decreased to ¥26,682 million from ¥46,300 million year-over-year.
Cash and cash equivalents at quarter-end were ¥425,295 million, up ¥163,035 million year-over-year.
Outlook and guidance
FY2024 full-year net sales forecast is ¥390,000 million, up 5.3% year-over-year.
Operating income is projected at ¥42,000 million, down 11.7% year-over-year.
Profit attributable to owners of parent is forecast at ¥26,000 million, a 17.4% decrease year-over-year.
Annual dividend forecast remains unchanged at ¥40 per share.
Latest events from Ibiden
- Strong Q3 growth, stock split, and major investment plan to boost high-performance IC substrate capacity.4062
Q3 20263 Feb 2026 - Strong sales and profit growth, stock split, and robust outlook driven by electronics.4062
Q2 202631 Oct 2025 - Strong first-quarter growth driven by electronics, with raised full-year outlook.4062
Q1 20261 Aug 2025 - Profit growth offset lower sales, but comprehensive income dropped on market-related losses.4062
Q2 202513 Jun 2025 - Profit rose 7% in FY2024, but FY2025 net profit is forecast to decline amid tariff risks.4062
Q4 20256 Jun 2025 - Q3 sales and profit declined, but gross margin and capital adequacy improved.4062
Q3 20255 Jun 2025